Evidence map›Paper›PMID 32556277›Full record

ArticleThe Journal of clinical endocrinology and metabolism2020

Determinants of Bone Material Strength and Cortical Porosity in Patients with Type 2 Diabetes Mellitus.

Parinya Samakkarnthai, Jad G Sfeir, Elizabeth J Atkinson, Sara J Achenbach, Paul W Wennberg, Peter J Dyck, Amanda J Tweed, Tammie L Volkman, Shreyasee Amin, Joshua N Farr and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Differences and similarities in cortical bone of the femur between donors with and without type 2 diabetes.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Associations between bone material strength index and FRAX scores.Journal of bone and mineral metabolism · 2025
    Article
  13. Review
  14. Review
  15. A Randomized Controlled Trial on the Effect of Luseogliflozin on Bone Microarchitecture Evaluated Using HR-pQCT in Elderly Type 2 Diabetes.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2024
    Article
  16. Observational
  17. Review
  18. Bone Loss in Diabetes Mellitus: Diaporosis.International journal of molecular sciences · 2024
    Review
  19. Article
  20. Bone Health in Patients With Type 2 Diabetes.Journal of the Endocrine Society · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 2 countries.

Parinya SamakkarnthaiRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Jad G SfeirRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Elizabeth J AtkinsonDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Sara J AchenbachDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Paul W WennbergDepartment of Cardiovascular Diseases and Gonda Vascular Center, Mayo Clinic, Rochester, Minnesota.
Peter J DyckDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Amanda J TweedRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Tammie L VolkmanRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Shreyasee AminDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Joshua N FarrRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Adrian VellaRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Matthew T DrakeRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Sundeep KhoslaRobert and Arlene Kogod Center on Aging and Division of Endocrinology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

Mayo Clinic Center for Clinical and Translational Science (CCaTS UL1 Supplement - Dr. Timothy Curry)UL1TR002377 · NCATS · MAYO CLINIC ROCHESTER · PI VESNA D GAROVIC · 2017 to 2026
$78.4M
EPIDEMIOLOGY OF AGE-RELATED BONE LOSS, &FRACTURESR01AR027065 · NIAMS · MAYO CLINIC ROCHESTER · PI AMIN, SHREYASEE, KHOSLA, SUNDEEP · 1986 to 2020
$14.9M
Targeting Cellular Senescence and RAGE in Type 2 DiabetesR01DK128552 · NIDDK · UNIVERSITY OF ARIZONA · PI FARR, JOSHUA NICHOLAS · 2021 to 2025
$2.0M
NCATS NIH HHS UL1 TR002377NIAMS NIH HHS R01 AR027065NIDDK NIH HHS R01 DK128552
6 · The paper itself

Abstract

contextReduced bone material strength index (BMSi) and increased cortical porosity (CtPo) have emerged as potentially contributing to fracture risk in type 2 diabetes mellitus (T2DM) patients.

objectiveTo determine whether BMSi or CtPo are related to other diabetic complications.

designCross-sectional observational study.

settingSubjects recruited from a random sample of southeast Minnesota residents.

participantsA total of 171 T2DM patients (mean age, 68.8 years) and 108 age-matched nondiabetic controls (mean age, 67.3 years). MAIN MEASURES: Bone material strength index was measured using microindentation, skin advanced glycation end-products (AGEs) measured using autofluorescence, high-resolution peripheral quantitative computed tomography at the distal radius and tibia, assessment of diabetic microvascular complications including urine microalbuminuria, retinopathy, neuropathy, and vascular disease (ankle brachial index and transcutaneous oxygen tension [TcPO2]). All analyses were adjusted for age, sex, and body mass index.

resultsSkin AGEs were negatively correlated with the BMSi in both T2DM (r = -0.30, P < 0.001) and control (r = -0.23, P = 0.020) subjects. In relating diabetic complications to CtPo, we found that T2DM patients with clinically significant peripheral vascular disease (TcPO2 ≤ 40 mm Hg) had higher (+21.0%, P = 0.031) CtPo at the distal tibia as compared to controls; in these subjects, CtPo was negatively correlated with TcPO2 at both the distal tibia (r = -0.39, P = 0.041) and radius (r = -0.41, P = 0.029).

conclusionsOur findings demonstrate that bone material properties are related to AGE accumulation regardless of diabetes status, while CtPo in T2DM patients is linked to TcPO2, a measure of microvascular blood flow.

Indexed as

AgedAnkle Brachial IndexBone DensityCross-Sectional StudiesDiabetes Mellitus, Type 2Diabetic AngiopathiesFemaleGlycation End Products, AdvancedHumansMaleMiddle AgedOsteoporotic FracturesPorosityRadiusRisk FactorsSkinGlycation End Products, AdvancedAGEsbonediabetesosteoporosisvascular disease

Identifiers

PMID32556277
PMCPMC7458544
OpenAlexW3036265119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.